FIELD: medicine.
SUBSTANCE: invention relates to field of pharmacology and medicine and represents rifampicin-based medication of prolonged action for treatment of resistant tuberculosis forms, which is different because it represents stable nanoparticles and contains rifampicic, biodegradable polymer of lactic acid or copolymer of lactic and glycolic acid, as well as surface active substance, cryoprotector, components in medication being in specified ratio in wt %.
EFFECT: invention ensures reduction of risk of toxic effects, prolonged action and reduction of intake factor in treatment.
6 cl, 3 ex, 1 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| D-CYCLOSERIN-BASED MEDICATION OF PLOLONGED ACTION WITH DOSED RELEASE IN TARGET ORGANS FOR TREATMENT OF RESISTANT FORMS OF TUBERCULOSIS | 2008 |
|
RU2403041C2 |
| ANTIBACTERIAL AGENT FOR TREATMENT OF INTRACELLULAR INFECTION | 2006 |
|
RU2308970C1 |
| AGENT FOR BACTERIAL INFECTIONS TREATMENT | 2007 |
|
RU2337711C1 |
| ANTIMICROBIAL MEDICINAL AGENT, METHOD OF PRODUCTION OF DIRECTIONAL MEDICINAL AGENT CONTAINIG NANOPARTICLES | 2007 |
|
RU2327459C1 |
| MEDICINAL AGENT BASED ON RYBAFUTIN, AGENT OF ANTIMICROBIC ACTION CONTAINING NANOPARTICLES, AND RELATED METHOD OF PRODUCTION | 2007 |
|
RU2327457C1 |
| D-CYCLOSERINE-BASE DRUG, NANOPARTICLES-CONTAINING PREPARATION OF PROLONGED EFFECT, METHOD FOR ITS PREPARING | 2007 |
|
RU2318513C1 |
| POLYMER CONTAINING MEDICINAL AGENT BASED ON ANTITUMOR AGENT ETOPOSIDE | 2015 |
|
RU2595859C1 |
| DRUG PREPARATION FOR PARKINSON DISEASE | 2014 |
|
RU2545734C1 |
| PROLONGED-RELEASE ANTITUMOUR THERAPEUTIC AGENT BASED ON ANASTROZOLE, ANTITUMOUR PREPARATION, OESTROGEN SYNTHESIS INHIBITOR | 2013 |
|
RU2548722C1 |
| DRUG OF ANTI-TUBERCULOSIS ACTION ON THE BASIS OF D-CYCLOSERINE IN THE FORM OF A LYOPHILISATE AND METHOD OF PRODUCING A MEDICINAL PREPARATION | 2015 |
|
RU2606839C1 |
